Form 4: Vertex Pharmaceuticals Executive Amit Sachdev Reports Stock Transaction
SEC Form 4 Filing
EVP, Chief Patient & External Affairs Officer of Vertex Pharmaceuticals, Amit Sachdev, reports disposition of shares to cover tax obligations.
Summary
- On February 24, 2025, Amit Sachdev, EVP, Chief Patient & External Affairs Officer of Vertex Pharmaceuticals, reported a transaction involving common stock.
- 2,470 shares were disposed of at a price of $483.28 to cover tax obligations.
- Following the transaction, Sachdev directly owns 72,193 shares of common stock and indirectly owns 882 shares through a 401(k).
Sentiment
Score: 5
Explanation: Neutral sentiment as the document is a standard regulatory filing detailing a routine stock transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders engage in transactions involving their company's stock. This provides transparency to the market.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares by an executive for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Date of stock transaction |
| 02/26/2025 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.